创新-话题@MedSci

#创新#

1015篇内容 | 8086人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1286029, encodeId=0d7a128602955, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=在非权威的医院工作，如何开展创新型较强的治疗方案？, objectType=article, longId=216015, objectId=e7d521601585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7d521601585, replyNumber=0, likeNumber=65, createdTime=2021-08-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7d521601585, moduleTitle=在非权威的医院工作，如何开展创新型较强的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7d521601585)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286047, encodeId=08e0128604eea, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=创新与科技赋能，我国糖尿病管理生态正走向数字化, objectType=article, longId=215879, objectId=0b532158e931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b532158e931, replyNumber=0, likeNumber=54, createdTime=2021-08-19, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b532158e931, moduleTitle=创新与科技赋能，我国糖尿病管理生态正走向数字化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b532158e931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286028, encodeId=f9301286028b0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=IBM 登陆 2021全球数字经济大会：AI 等高科技如何推动医疗健康创新, objectType=article, longId=215699, objectId=4dd02156995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dd02156995e, replyNumber=0, likeNumber=76, createdTime=2021-08-15, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dd02156995e, moduleTitle=IBM 登陆 2021全球数字经济大会：AI 等高科技如何推动医疗健康创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dd02156995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286057, encodeId=7fbe128605eec, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, objectType=article, longId=215654, objectId=a5a921565425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5a921565425, replyNumber=0, likeNumber=71, createdTime=2021-08-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5a921565425, moduleTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5a921565425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286025, encodeId=77ae128602564, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=君实生物与嘉晨西海宣布将成立合资公司共同开发自复制与常规mRNA创新药物及疫苗, objectType=article, longId=214499, objectId=75be214499fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75be214499fa, replyNumber=0, likeNumber=57, createdTime=2021-07-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75be214499fa, moduleTitle=君实生物与嘉晨西海宣布将成立合资公司共同开发自复制与常规mRNA创新药物及疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75be214499fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286024, encodeId=f756128602484, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=首届AI药物研发创新研讨会在沪举行 , objectType=article, longId=214482, objectId=7fb1214482aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb1214482aa, replyNumber=0, likeNumber=67, createdTime=2021-07-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb1214482aa, moduleTitle=首届AI药物研发创新研讨会在沪举行 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb1214482aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286023, encodeId=360f12860236b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年上半年盘点：NMPA批准了哪些创新药物？, objectType=article, longId=213743, objectId=0570213e43d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0570213e43d6, replyNumber=0, likeNumber=66, createdTime=2021-07-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0570213e43d6, moduleTitle=2021年上半年盘点：NMPA批准了哪些创新药物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0570213e43d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286022, encodeId=4e6012860228e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年上半年盘点：NMPA批准了哪些癌症创新药物？, objectType=article, longId=213740, objectId=9ffc213e403f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ffc213e403f, replyNumber=0, likeNumber=76, createdTime=2021-07-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ffc213e403f, moduleTitle=2021年上半年盘点：NMPA批准了哪些癌症创新药物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ffc213e403f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286021, encodeId=02d6128602190, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=半年内国产6款Claudin18.2创新药物获批临床，全球在研进入热潮, objectType=article, longId=213325, objectId=1e4921332598, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4921332598, replyNumber=0, likeNumber=82, createdTime=2021-06-28, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4921332598, moduleTitle=半年内国产6款Claudin18.2创新药物获批临床，全球在研进入热潮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4921332598)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286020, encodeId=899b12860208a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年6月18日：31省份已累计报告接种新冠病毒疫苗99025.7万剂次，新增2360.5万剂次，再创新高, objectType=article, longId=212940, objectId=a737212940ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a737212940ae, replyNumber=0, likeNumber=69, createdTime=2021-06-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a737212940ae, moduleTitle=2021年6月18日：31省份已累计报告接种新冠病毒疫苗99025.7万剂次，新增2360.5万剂次，再创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a737212940ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286018, encodeId=f71012860185b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, objectType=article, longId=212564, objectId=6f2921256483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2921256483, replyNumber=0, likeNumber=88, createdTime=2021-06-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2921256483, moduleTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2921256483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286017, encodeId=9268128601e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=NMPA近期一个月批准10款创新药, objectType=article, longId=212382, objectId=0aeb21238228, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aeb21238228, replyNumber=0, likeNumber=84, createdTime=2021-06-08, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aeb21238228, moduleTitle=NMPA近期一个月批准10款创新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aeb21238228)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286016, encodeId=774a128601638, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年6月2日：31省份已累计报告接种新冠病毒疫苗70482.6万剂次，新增2291.8万剂次，再创新高, objectType=article, longId=212240, objectId=446e212240ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446e212240ae, replyNumber=0, likeNumber=50, createdTime=2021-06-05, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446e212240ae, moduleTitle=2021年6月2日：31省份已累计报告接种新冠病毒疫苗70482.6万剂次，新增2291.8万剂次，再创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446e212240ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286094, encodeId=e6e61286094f7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速, objectType=article, longId=212230, objectId=e6b82122304a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6b82122304a, replyNumber=0, likeNumber=63, createdTime=2021-06-05, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6b82122304a, moduleTitle=联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6b82122304a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286015, encodeId=20bf128601554, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年5月31日：31省份已累计报告接种新冠病毒疫苗66146.8万剂次，新增2229.6万剂次，再创新高, objectType=article, longId=212158, objectId=aeb821215858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeb821215858, replyNumber=0, likeNumber=62, createdTime=2021-06-03, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeb821215858, moduleTitle=2021年5月31日：31省份已累计报告接种新冠病毒疫苗66146.8万剂次，新增2229.6万剂次，再创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aeb821215858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286014, encodeId=3686128601478, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=两院院士大会，你读懂了多少科技创新内容？全文和重点都在这里！, objectType=article, longId=212052, objectId=577521205202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=577521205202, replyNumber=0, likeNumber=0, createdTime=2021-06-01, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=577521205202, moduleTitle=两院院士大会，你读懂了多少科技创新内容？全文和重点都在这里！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=577521205202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286013, encodeId=78d71286013f1, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！, objectType=article, longId=212035, objectId=c85821203549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c85821203549, replyNumber=0, likeNumber=75, createdTime=2021-05-31, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c85821203549, moduleTitle=OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c85821203549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286012, encodeId=9f7d128601202, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, objectType=article, longId=211976, objectId=8fc22119e6c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fc22119e6c8, replyNumber=0, likeNumber=28, createdTime=2021-05-30, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fc22119e6c8, moduleTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fc22119e6c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286011, encodeId=dadf128601145, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021年5月25日：31省份已累计报告接种新冠病毒疫苗54671.4万剂次，新增1946.1万剂次，再创新高, objectType=article, longId=211904, objectId=687321190402, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=687321190402, replyNumber=0, likeNumber=49, createdTime=2021-05-28, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687321190402, moduleTitle=2021年5月25日：31省份已累计报告接种新冠病毒疫苗54671.4万剂次，新增1946.1万剂次，再创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687321190402)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286010, encodeId=762d1286010f4, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床, objectType=article, longId=211775, objectId=e164211e7541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e164211e7541, replyNumber=0, likeNumber=75, createdTime=2021-05-26, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e164211e7541, moduleTitle=无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e164211e7541)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

在非权威的医院工作，如何开展创新型较强的治疗方案？

2021-08-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

创新与科技赋能，我国糖尿病管理生态正走向数字化

2021-08-19

lilianxiang (审核中...)

前往app查看评论内容

#创新#

IBM 登陆 2021全球数字经济大会：AI 等高科技如何推动医疗健康创新

2021-08-15

lilianxiang (审核中...)

前往app查看评论内容

#创新#

淋巴瘤创新药佳罗华®进入2021年国家医保目录

2021-08-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

君实生物与嘉晨西海宣布将成立合资公司共同开发自复制与常规mRNA创新药物及疫苗

2021-07-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

首届AI药物研发创新研讨会在沪举行

2021-07-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年上半年盘点：NMPA批准了哪些创新药物？

2021-07-06

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年上半年盘点：NMPA批准了哪些癌症创新药物？

2021-07-06

lilianxiang (审核中...)

前往app查看评论内容

#创新#

半年内国产6款Claudin18.2创新药物获批临床，全球在研进入热潮

2021-06-28

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年6月18日：31省份已累计报告接种新冠病毒疫苗99025.7万剂次，新增2360.5万剂次，再创新高

2021-06-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用

2021-06-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

NMPA近期一个月批准10款创新药

2021-06-08

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年6月2日：31省份已累计报告接种新冠病毒疫苗70482.6万剂次，新增2291.8万剂次，再创新高

2021-06-05

lilianxiang (审核中...)

前往app查看评论内容

#创新#

联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速

2021-06-05

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年5月31日：31省份已累计报告接种新冠病毒疫苗66146.8万剂次，新增2229.6万剂次，再创新高

2021-06-03

lilianxiang (审核中...)

前往app查看评论内容

#创新#

两院院士大会，你读懂了多少科技创新内容？全文和重点都在这里！

2021-06-01

lilianxiang (审核中...)

前往app查看评论内容

#创新#

OCC 2021丨变革创新进阶 ——第十五届东方心脏病学会议开幕！

2021-05-31

lilianxiang (审核中...)

前往app查看评论内容

#创新#

会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕

2021-05-30

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021年5月25日：31省份已累计报告接种新冠病毒疫苗54671.4万剂次，新增1946.1万剂次，再创新高

2021-05-28

lilianxiang (审核中...)

前往app查看评论内容

#创新#

无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床

2021-05-26

科室
- - 订阅+
  - 更多科室
工具
服务